CHAMPIONS ONCOLOGY, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Champions Oncology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q2 2024.
  • Champions Oncology, Inc. Share-based Payment Arrangement, Expense for the quarter ending July 31, 2024 was $258K, a 39% decline year-over-year.
  • Champions Oncology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending July 31, 2024 was $953K, a 11.8% decline year-over-year.
  • Champions Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.12M, a 29.4% increase from 2022.
  • Champions Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $864K, a 5.26% decline from 2021.
  • Champions Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $912K, a 52.5% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $953K $258K -$165K -39% May 1, 2024 Jul 31, 2024 10-Q 2024-09-13
Q1 2024 $1.12M $263K +$55K +26.4% Feb 1, 2024 Apr 30, 2024 10-K 2024-07-19
Q4 2023 $1.06M $379K +$48K +14.5% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-15
Q3 2023 $1.02M $53K -$66K -55.5% Aug 1, 2023 Oct 31, 2023 10-Q 2023-12-13
Q2 2023 $1.08M $423K +$217K +105% May 1, 2023 Jul 31, 2023 10-Q 2024-09-13
Q1 2023 $864K $208K +$20K +10.6% Feb 1, 2023 Apr 30, 2023 10-K 2024-07-19
Q4 2022 $844K $331K +$21K +6.77% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-15
Q3 2022 $823K $119K -$15K -11.2% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-13
Q2 2022 $838K $206K -$74K -26.4% May 1, 2022 Jul 31, 2022 10-Q 2023-09-13
Q1 2022 $912K $188K +$27K +16.8% Feb 1, 2022 Apr 30, 2022 10-K 2023-07-24
Q4 2021 $885K $310K +$78K +33.6% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-16
Q3 2021 $807K $134K +$49K +57.6% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-13
Q2 2021 $758K $280K +$160K +133% May 1, 2021 Jul 31, 2021 10-Q 2022-09-12
Q1 2021 $598K $161K -$2K -1.23% Feb 1, 2021 Apr 30, 2021 10-K 2022-07-22
Q4 2020 $600K $232K +$3K +1.31% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-15
Q3 2020 $597K $85K +$8K +10.4% Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-13
Q2 2020 $589K $120K -$11K -8.4% May 1, 2020 Jul 31, 2020 10-Q 2021-09-13
Q1 2020 $600K $163K +$20K +14% Feb 1, 2020 Apr 30, 2020 10-K 2021-07-26
Q4 2019 $580K $229K -$106K -31.6% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-15
Q3 2019 $686K $77K -$11K -12.5% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-14
Q2 2019 $697K $131K +$48K +57.8% May 1, 2019 Jul 31, 2019 10-Q 2020-09-14
Q1 2019 $649K $143K -$27K -15.9% Feb 1, 2019 Apr 30, 2019 10-K 2020-07-28
Q4 2018 $676K $335K +$183K +120% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-16
Q3 2018 $493K $88K -$60K -40.5% Aug 1, 2018 Oct 31, 2018 10-Q 2019-12-16
Q2 2018 $553K $83K -$481K -85.3% May 1, 2018 Jul 31, 2018 10-Q 2019-09-16
Q1 2018 $1.03M $170K -$591K -77.7% Feb 1, 2018 Apr 30, 2018 10-K 2019-07-29
Q4 2017 $1.63M $152K -$85K -35.9% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-18
Q3 2017 $1.71M $148K -$387K -72.3% Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-17
Q2 2017 $2.1M $564K -$565K -50% May 1, 2017 Jul 31, 2017 10-Q 2018-09-14
Q1 2017 $2.66M $761K +$252K +49.5% Feb 1, 2017 Apr 30, 2017 10-K 2018-07-30
Q4 2016 $2.41M $237K -$330K -58.2% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-19
Q3 2016 $2.74M $535K -$213K -28.5% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-15
Q2 2016 $2.95M $1.13M +$354K +45.7% May 1, 2016 Jul 31, 2016 10-Q 2017-09-14
Q1 2016 $2.6M $509K -$368K -42% Feb 1, 2016 Apr 30, 2016 10-K 2017-07-28
Q4 2015 $2.97M $567K -$90K -13.7% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-17
Q3 2015 $3.06M $748K -$72K -8.78% Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-14
Q2 2015 $3.13M $775K -$33K -4.08% May 1, 2015 Jul 31, 2015 10-Q 2016-09-14
Q1 2015 $3.16M $877K +$39K +4.65% Feb 1, 2015 Apr 30, 2015 10-K 2016-07-29
Q4 2014 $3.12M $657K -$284K -30.2% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-16
Q3 2014 $3.41M $820K +$344K +72.3% Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-15
Q2 2014 $3.06M $808K +$256K +46.4% May 1, 2014 Jul 31, 2014 10-Q 2015-09-11
Q1 2014 $2.81M $838K +$395K +89.2% Feb 1, 2014 Apr 30, 2014 10-K 2015-07-29
Q4 2013 $2.41M $941K +$371K +65.1% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-17
Q3 2013 $2.04M $476K -$148K -23.7% Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-15
Q2 2013 $2.19M $552K -$187K -25.3% May 1, 2013 Jul 31, 2013 10-Q 2014-09-12
Q1 2013 $2.38M $443K -$268K -37.7% Feb 1, 2013 Apr 30, 2013 10-K 2014-07-28
Q4 2012 $2.64M $570K -$173K -23.3% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-14
Q3 2012 $2.82M $624K -$231K -27% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-13
Q2 2012 $3.05M $739K -$275K -27.1% May 1, 2012 Jul 31, 2012 10-Q 2013-09-13
Q1 2012 $3.32M $711K Feb 1, 2012 Apr 30, 2012 10-K 2013-07-26
Q4 2011 $743K Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-13
Q3 2011 $855K Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-13
Q2 2011 $1.01M May 1, 2011 Jul 31, 2011 10-Q 2012-09-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.